You are here
- Home
- Rare lung diseases
Rare lung diseases
- Predictors of postoperative acute exacerbation of interstitial lung disease: a case–control studyKeisuke Hosoki, Yu Mikami, Hirokazu Urushiyama, Kunihiko Souma, Gaku Kawamura, Kanji Uchida, Takahide Nagase, Taisuke JoBMJ Open Respiratory Research Oct 2020, 7 (1) e000634; DOI: 10.1136/bmjresp-2020-000634
- SARS-CoV-2 organising pneumonia: ‘Has there been a widespread failure to identify and treat this prevalent condition in COVID-19?’Pierre Kory, Jeffrey P KanneBMJ Open Respiratory Research Sep 2020, 7 (1) e000724; DOI: 10.1136/bmjresp-2020-000724
- Current and future management of non-tuberculous mycobacterial pulmonary disease (NTM-PD) in the UKMarc Lipman, Joanne Cleverley, Tom Fardon, Besma Musaddaq, Daniel Peckham, Roald van der Laan, Paul Whitaker, Jacqui WhiteBMJ Open Respiratory Research Jun 2020, 7 (1) e000591; DOI: 10.1136/bmjresp-2020-000591
- The effects of sildenafil on ciliary beat frequency in patients with pulmonary non-tuberculous mycobacteria disease: phase I/II trialCedar Fowler, Un-In Wu, Robyn Shaffer, Caroline Smith, Lisa Barnhart, Clare Bryant, Kenneth Olivier, Steven M HollandBMJ Open Respiratory Research Mar 2020, 7 (1) e000574; DOI: 10.1136/bmjresp-2020-000574
- Rationale, design and objectives of two phase III, randomised, placebo-controlled studies of GLPG1690, a novel autotaxin inhibitor, in idiopathic pulmonary fibrosis (ISABELA 1 and 2)Toby M Maher, Michael Kreuter, David J Lederer, Kevin K Brown, Wim Wuyts, Nadia Verbruggen, Simone Stutvoet, Ann Fieuw, Paul Ford, Walid Abi-Saab, Marlies WijsenbeekBMJ Open Respiratory Research May 2019, 6 (1) e000422; DOI: 10.1136/bmjresp-2019-000422
- Veterans Specific Activity Questionnaire (VSAQ): a new and efficient method of assessing exercise capacity in patients with pulmonary arteriovenous malformationsFilip Gawecki, Jonathan Myers, Claire L. ShovlinBMJ Open Respiratory Research Mar 2019, 6 (1) e000351; DOI: 10.1136/bmjresp-2018-000351
- Baseline clinical characteristics, comorbidities and prescribed medication in a real-world population of patients with idiopathic pulmonary fibrosis: the PROOF registryWim A Wuyts, Caroline Dahlqvist, Hans Slabbynck, Marc Schlesser, Natacha Gusbin, Christophe Compere, Sofie Maddens, Klaus-Uwe Kirchgaessler, Karen Bartley, Benjamin BondueBMJ Open Respiratory Research Nov 2018, 5 (1) e000331; DOI: 10.1136/bmjresp-2018-000331
- Psychometric properties of the St George’s Respiratory Questionnaire in patients with idiopathic pulmonary fibrosis: insights from the INPULSIS trialsJeffrey J Swigris, Hilary Wilson, Dirk Esser, Craig S Conoscenti, Wibke Stansen, Nancy Kline Leidy, Kevin K BrownBMJ Open Respiratory Research May 2018, 5 (1) e000278; DOI: 10.1136/bmjresp-2018-000278
- Pulmonary involvement in Fabry disease: effect of plasma globotriaosylsphingosine and time to initiation of enzyme replacement therapyDaniel Franzen, Sarah R Haile, David C Kasper, Thomas P Mechtler, Andreas J Flammer, Pierre A Krayenbühl, Albina NowakBMJ Open Respiratory Research Apr 2018, 5 (1) e000277; DOI: 10.1136/bmjresp-2018-000277
- Long-term outcomes of patients with pulmonary arteriovenous malformations considered for lung transplantation, compared with similarly hypoxaemic cohortsClaire L Shovlin, Elisabetta Buscarini, J Michael B Hughes, David J Allison, James E JacksonBMJ Open Respiratory Research Oct 2017, 4 (1) e000198; DOI: 10.1136/bmjresp-2017-000198
Pages
- BMJ Open Respiratory Research
- Cough (3)
- Critical care (8)
- Cystic fibrosis (3)
- Lung cancer (9)
- Sleep (2)
- Thoracic surgery (1)
- Tuberculosis (2)